News & Updates
Showing Cardiology articles
Showing

SGLT2 inhibitors show renal benefits vs GLP-1 RAs in T2D patients in the real world
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are superior to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in reducing renal outcomes among patients with type 2 diabetes (T2D) in Hong Kong, a real-world population-based study by the University of Hong Kong has shown.

Neutrophils release more cytokines in DM, HFpEF patients
In patients with type 2 diabetes mellitus (DM) or heart failure with preserved ejection fraction (HFpEF), neutrophils seem to secrete more cytokines, contributing to low-grade chronic inflammation, a recent study reports.

Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines
The risk of myopericarditis after COVID-19 vaccination is not greater than that following other non–COVID-19 vaccinations, according to a systematic review and meta-analysis conducted by researchers in Singapore.

CPET a useful cardiovascular risk assessment tool for patients undergoing cancer surgery
For patients undergoing surgery for oesophageal and gastric cancer, cardiopulmonary exercise testing (CPET) appears to be a reliable predictor of major cardiovascular complications, as reported in a study.




